SBIR/STTR Research Award
A MORE DURABLE AND UNIVERSAL ADJUVANTED INFLUENZA VACCINE THROUGH SYNTHETIC BIOLOGY
Award amount
$599,526Program and phase
SBIR · Phase IAward year
2025Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- Enepret Incorporated
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- P3KJFJJR58R4
- Solicitation number
- PHS 2025-1
- Topic code
- 140
Research abstract
Technology to develop and produce vaccines that offer broader protections against constantly mutating pathogens has been a continuing challenge.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- INCREASING AVAILABILITY OF EMULSION ADJUVANTS VIA SYNTHETIC BIOLOGY
- Evaluating Synthetic Biology Produced Triterpene Oils in Adjuvant Formulations
Research funding history
3 SBIR/STTR records share this UEI (2018–2025). Reported award amounts total $3,820,540. Reported amounts are not federal obligations.
Phases: Phase I, Phase II – Direct to Phase II
Agencies: Department of Health and Human Services